Ocular Development and Refractive Error Changes Among Children and Adolescent - A Longitudinal Study

March 14, 2022 updated by: Yizhi Liu, Zhongshan Ophthalmic Center, Sun Yat-sen University

A Longitudinal Study on Ocular Development and Refractive Error Changes Among children-and Adolescent

The study aims to observe the ocular development and refractive error changes among school children and adolescents

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

This study aims to observe the refractive error changes of school children and adolescents for 3 years, and to collect data of ocular structural parameters, family history and environmental factors so as to understand the natural course and internal laws of myopia progression.

Study Type

Observational

Enrollment (Actual)

7050

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Zengcheng
      • Guangzhou, Guangdong, China
        • Zengcheng

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 12 years (Child)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

School children and adolescent at the age of 3(Junior Kindergarten), 6(Grade 1), 9(grade 4), 12(grade 7)

Description

Inclusion Criteria:

  • School children and adolescent at the age of 3(Junior Kindergarten), 6(Grade 1), 9(grade 4), 12(grade 7).
  • No allergy to tropicamide or topical anesthetics
  • written informed consent is obtained from guardian
  • Be willing to cooperate with the relevant ophthalmological examination and complete the questionnaire.

Exclusion Criteria:

  • No history of eye diseases
  • Receiving or has been received treatment of myopia control such as atropine eye drops, corneal contact lens or myopic glasses
  • A history of allergy to topic amide or topical anesthetics
  • Have severe systemic disease
  • Missing ability to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
spherical equivalent change
Time Frame: examine every 12 months, follow up for 3 years
SE was measured by autorefractometer with cycloplegic once a year at scheduled time Every 12 months, follow up for 3 years
examine every 12 months, follow up for 3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Axial length
Time Frame: examine every 12 months, follow up for 3 years
Axial length is measured by IOMaster once a year at scheduled time
examine every 12 months, follow up for 3 years
Anterior chamber depth
Time Frame: examine every 12 months, follow up for 3 years
Anterior chamber depth is measured by IOMaster once a year at scheduled time
examine every 12 months, follow up for 3 years
lens thickness
Time Frame: examine every 12 months, follow up for 3 years
lens thickness is measured by IOMaster once a year at scheduled time
examine every 12 months, follow up for 3 years
Vitreous length
Time Frame: examine every 12 months, follow up for 3 years
Vitreous length was measured by IOMaster once a year at scheduled time
examine every 12 months, follow up for 3 years
Environmental factor
Time Frame: examine every 12 months, follow up for 3 years
Time of outdoor activities & short range reading,measured by questionnaire
examine every 12 months, follow up for 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yizhi LIU, PhD, Zhongshan Ophthalmic Center, Sun Yat-san University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2018

Primary Completion (Anticipated)

July 20, 2024

Study Completion (Anticipated)

July 20, 2024

Study Registration Dates

First Submitted

June 20, 2018

First Submitted That Met QC Criteria

July 17, 2018

First Posted (Actual)

July 18, 2018

Study Record Updates

Last Update Posted (Actual)

March 29, 2022

Last Update Submitted That Met QC Criteria

March 14, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SYSU-OPH-004

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Subscribe